Letaplimab represents a unique medical method for addressing complement-mediated conditions. This monoclonal antibody targets C1q, a critical component of the complement system, effectively disrupt its early https://aishadxij508546.pointblog.net/letaplimab-a-new-therapeutic-approach-92231503